We’re proud to share that SpOvum Technologies has been featured in ITMatters, in their Tech That Matters series, recognizing our mission to revolutionize fertility care in India through AI-driven, compassionate technology.
The article highlights how SpOvum is addressing critical challenges in IVF — from high costs and fragile procedures to inconsistent outcomes — by developing innovative, locally designed solutions. Our flagship product, RoboICSI®, was noted as a game-changer for its ability to automate the delicate ICSI procedure with greater precision, reduced risk to oocytes, and improved fertilization rates, while also making the process less dependent on elite-level expertise.
ITMatters also spotlighted our commitment to ethics and transparency in AI, our efforts to make advanced fertility technology accessible in Tier II and III cities, and our broader vision to democratize IVF care so that quality treatment becomes a right, not a privilege.
This recognition further fuels our drive to make IVF safer, more efficient, and more affordable for clinics and patients alike — delivering not just cutting-edge tools, but also hope and trust in every step of the journey.
We are proud to share that SpOvum Technologies has been featured in The Economic Times, one of India’s most respected business publications, for our groundbreaking work in applying AI to Assisted Reproductive Technologies (ART).
In an article exploring how AI is transforming India’s healthcare landscape, SpOvum was spotlighted for our pioneering RoboICSI system, which uses artificial intelligence to reduce human error and enhance IVF outcomes. Co-founder Dr. Ramnath Babu was quoted explaining how RoboICSI ensures zero percent oocyte degeneration by recognizing complex patterns across 200+ variables—supporting embryologists and protecting the integrity of every procedure.
With over 2,000 IVF procedures supported and partnerships with 41 IVF clinics across India, SpOvum continues to set new benchmarks in fertility care by combining robotics, AI, and clinical insight.
This recognition is not just a milestone for us—it’s a testament to our vision of making fertility treatments more precise, consistent, and accessible for every aspiring parent.
We’re excited to share that SpOvum Technologies was recently featured in Deccan Herald‘s science section in an article titled “Bioengineered Baby”. The article explores the evolution of IVF and highlights key innovators and technologies shaping the future of assisted reproduction.
Our co-founders, Dr. Santosh Bhargav and Dr. Ramnath Babu, were mentioned for their pioneering work at the intersection of mechanical engineering and reproductive biology. The article spotlighted RoboICSI, our robotic micromanipulation system designed to enhance precision during sperm injection—aiming to reduce egg damage and improve IVF outcomes. It also highlighted our commitment to automation and AI-driven lab data monitoring that supports improved embryo culture environments.
We are thrilled to share that SpOvum Technologies has been featured in YourStory — one of India’s most respected startup and innovation platforms!
The article, titled “This deeptech startup is making fertility treatments smarter, accessible, and effective”, shines a spotlight on our mission to revolutionize the Assisted Reproductive Technology (ART) landscape through AI, robotics, and automation.
The story highlights how our founders, Dr. Ramnath Babu T J and Dr. Santosh Bhargav D B, identified the inefficiencies in traditional IVF labs and took a bold step to transform the system from the ground up. With roots at IISc Bengaluru and backgrounds in mechanical engineering, they’ve built SpOvum to solve core problems in fertility care — from lab precision and compliance to data-driven clinical decisions.
Key Highlights from the Feature:
India faces growing infertility challenges, and IVF remains costly and inconsistent.
SpOvum addresses this through products like RoboICSI, Time-lapse Imaging Incubator, ART Dashboard, and AI Decision Support tools.
Our solutions bring affordability, scalability, and precision to fertility clinics, especially in Tier II and Tier III cities.
Clinics using SpOvum have seen IVF success rates jump from 35% to over 50%.
With 30+ partner clinics across four states and plans to scale to 100 clinics, SpOvum continues to grow rapidly.
We thank YourStory for this recognition and remain committed to building the future of ethical, accessible, and effective fertility care.
We’re excited to share that SpOvum Technologies has been featured in a recent article on IndiaMedToday, a leading healthcare publication, for our groundbreaking collaboration with Khushi Fertility, led by Dr. Rashmi Yogish.
This feature highlights a first-of-its-kind partnership where SpOvum will take the lead in training and upskilling embryologists, ensuring standardised, high-quality practices across all Khushi Fertility centres. Through this strategic alliance, we aim to integrate our advanced Lab Management System (LMS), cutting-edge software, and proprietary hardware into their clinical ecosystem.
In the article, our Co-Founders Dr. Ramnath Babu T J (CEO) and Dr. Santosh Bhargav D B (CTO) shared their vision for building scalable, smart, and patient-centric IVF infrastructure in India. They emphasized how this collaboration will drive real-time R&D, accelerate innovation in AI-powered lab automation, and enhance embryologist performance and patient outcomes.
We’re proud to see our efforts recognised by IndiaMedToday and excited about the future this partnership is shaping for the fertility industry.
We are excited to share that Dr. Santosh Bhargav D B, Co-Founder and CTO of SpOvum Technologies, has been featured in the esteemed E-Health Magazine — a leading voice in the healthcare industry.
In his expert column, Dr. Santosh highlights the growing importance of Lab Management Systems (LMS) in ensuring data consistency across IVF clinics. With increasing demands for accuracy and regulatory compliance in Assisted Reproductive Technology (ART), Dr. Santosh shares how LMS platforms can revolutionise the way fertility labs manage samples, treatment records, and clinical processes.
From automated sample tracking to centralised data storage and role-based access control, the article offers practical insights on how the right technology can drive efficiency, reduce errors, and support better patient outcomes.
We’re proud to see our thought leadership recognised in the healthcare space, and we remain committed to building innovative tech solutions for IVF and fertility care.
We are thrilled to share that our Co-founder and CEO, Dr. Ramnath Babu T J, has been featured in BW Healthcare World with his insightful article on AI and automation in the Indian IVF industry.
AI & Automation: The Future of Indian IVF
With infertility affecting nearly 17.5% of the global population, the demand for Assisted Reproductive Technologies (ART) is on the rise. Dr. Ramnath Babu’s article highlights how AI-driven innovations are revolutionizing IVF procedures by enhancing embryo selection, improving success rates, and personalizing treatment.
India’s Push for AI in Healthcare
The Indian government’s IndiaAI Mission, a $1.25 billion initiative, aims to integrate AI across industries, including reproductive medicine. With regulations like the ART Regulation Bill, India is moving towards a standardized, ethical, and technology-driven IVF landscape.
Spreading Awareness & Adoption
Despite advancements, lack of awareness remains a major challenge. Fertility centers, including those supported by SpOvum, are leveraging digital outreach and AI-driven solutions to educate couples and streamline treatments.
Overcoming Challenges, Embracing Opportunities
While concerns like affordability, infrastructure, and ethical AI use persist, the future looks promising. AI has the potential to make IVF more efficient, affordable, and accessible, turning challenges into opportunities for aspiring parents.
We at SpOvum Technologies are committed to driving this transformation, supporting IVF clinics with innovative tech solutions. Read the full article on BW Healthcare World to explore how AI is shaping the future of fertility treatments.
We are delighted to share that SpOvum Technologies has been featured in BioSpectrum India for our groundbreaking advancements in IVF workflow management. The article highlights SpOvum’s efforts in introducing the Integrated IVF Management Solution, a first-of-its-kind system designed to transform IVF workflows through innovation and precision.
About the Coverage
BioSpectrum India’s article emphasizes how SpOvum is setting new standards in assisted reproductive technology (ART) by integrating advanced solutions like:
Real-Time Lab Monitoring: Ensuring lab health through continuous monitoring and reporting.
Smart Witness Technology: Guaranteeing traceability and accuracy in gamete and consumable management.
Comprehensive Data Integration: Seamlessly linking patient data with lab processes for better workflow efficiency.
Compliance with ART Regulations: Streamlining adherence to industry standards while safeguarding patient trust.
The article further explores how SpOvum’s innovative system enhances patient care, minimizes errors, and provides data-driven insights to optimize IVF treatment outcomes.
Key Highlights from the Article
Efficiency and Accuracy: SpOvum’s system simplifies administrative tasks while enabling better resource allocation, leading to improved clinical outcomes.
Enhanced Transparency: Real-time tracking of lab activities and patient data ensures compliance and builds trust.
Cost-Effective Solutions: Automated workflows reduce manual errors and operational costs, offering long-term savings for IVF clinics.
Transforming Fertility Care
SpOvum’s Integrated IVF Management Solution represents a significant leap forward in reproductive healthcare. By focusing on time-saving mechanisms, improved accuracy, and patient-centric care, we are committed to empowering IVF clinics with the tools they need to achieve excellence.
Read the Full Story
We extend our heartfelt gratitude to BioSpectrum India for recognizing our efforts and featuring our contributions to advancing IVF technologies.
At SpOvum, we remain dedicated to revolutionizing fertility care through innovation and collaboration. This feature in BioSpectrum India reinforces our commitment to setting new benchmarks in the IVF and fertility industry.
National Startup Day 2025: Revolutionizing Fertility Care with AI and ML
We are thrilled to share that Dr. Ramnath Babu T J, Co-Founder and CEO of SpOvum Technologies, has been prominently quoted in eHealth Network’s article “National Startup Day 2025: Startups Shaping the Future of India’s Infertility with AI-ML.”
The article highlights the transformative role of startups in India’s fertility and IVF landscape, focusing on how AI and machine learning are reshaping reproductive healthcare. At SpOvum, we’re proud to be at the forefront of this revolution, enabling clinics to deliver better outcomes through advanced technology and innovation.
The Growing Need for Innovation in Fertility Care
Infertility affects 15–20% of couples in India, a number that has risen due to lifestyle changes, stress, and delayed childbearing. This rising trend emphasizes the urgent need for scientific, data-driven approaches to improve patient outcomes.
How AI and ML Are Transforming Fertility Treatments
The article sheds light on several areas where AI-ML technologies are making a difference in the fertility sector:
Improved Diagnostics: AI analyzes complex datasets to predict patient outcomes and identify underlying conditions, enabling better success rates.
Optimal Embryo Selection: By evaluating embryos on morphology and growth dynamics, AI ensures higher implantation rates.
Cryopreservation & Monitoring: AI enhances freezing and thawing processes for eggs and embryos, ensuring their viability.
Personalized Treatment Protocols: AI tailors treatment plans based on genetic, hormonal, and lifestyle data.
Automated Laboratory Workflows: AI-powered systems safeguard quality and reduce manual errors.
SpOvum’s Vision: Bridging the Gap in Fertility Care
Dr. Ramnath Babu emphasized the need for innovation and quality in India’s IVF industry. SpOvum’s technologies aim to set new benchmarks, ensuring that fertility treatments are effective and accessible across Tier 2 and Tier 3 cities.
A Milestone for SpOvum
We take immense pride in being part of the larger conversation around India’s health tech revolution. Dr. Ramnath’s insights in the eHealth article reflect SpOvum’s unwavering commitment to advancing fertility care through technology and innovation.
You can read the full article by eHealth Networkhere.
We are delighted to share that our Director, Dr. Santosh Bhargav D B, has been quoted in IndiaMed Today’s industry story, “Reimagining Indian Healthcare 2024: The Pulsating Start-up Ecosystem.”
IndiaMed Today is a leading publication dedicated to covering innovations and trends in India’s healthcare sector. This feature article explores the transformative impact of health tech startups, which are reshaping the healthcare landscape with cutting-edge technologies like AI, machine learning, and data analytics. The story sheds light on the challenges and opportunities faced by startups in navigating funding landscapes, ensuring quality, and driving innovation.
In the article, Dr. Santosh Bhargav shares SpOvum’s journey and insights:
“The IVF industry is not yet accustomed to Made-in-India products. Our competitors have set high-quality standards, and we recognize the need to match and surpass these benchmarks. Innovating and improving upon established expectations requires substantial preparation, rigorous quality control, and dedicated effort. By investing in R&D, strengthening our quality assurance measures, and building strategic collaborations, we are positioning ourselves to achieve sustainable growth and resilience in the year ahead.”
Dr. Santosh’s thoughts reflect SpOvum’s commitment to excellence in the IVF domain, with a focus on delivering world-class solutions that meet and exceed global standards.
The Larger Context
The feature highlights that 2024 has been a pivotal year for health tech startups in India, with over $9.9 billion raised by July 2024. Startups like SpOvum, Even.in, Sunfox Technologies, and Dozee have not only overcome significant challenges but have also contributed to transforming healthcare delivery and accessibility.
As a homegrown startup, SpOvum is proud to be part of this dynamic ecosystem, continuously working to innovate and deliver meaningful impact in the field of Assisted Reproductive Technology (ART).
